Menu

Experience

Charity Williams

    • Shoreline Enters Partnership with Kite 


    • Shoreline Enters Collaboration with BeiGene 


    • Horizon Pharma Acquisition of Crealta Holdings for $510 Million 


    • Horizon Pharma Buys River Vision for $145 Million and Unspecified Earn-Out 


    • Synthorx to Sell to Sanofi for $2.5 Billion 


    • ArcherDX Agrees to Combine With Invitae in $2.7 Billion Deal 


    • Rodeo Therapeutics Agrees to Sell to Amgen for $721 Million 


    • Shoreline Biosciences Enters Collaboration With BeiGene to Develop Genetically Modified Cell Therapies 


    • Resolution Bio Sells to Agilent 


    • Genomatica Joint Venture with Unilever 


    • Sixth Street Invests in Blueprint Medicines 


    • Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals 


    • Oyster Point Pharma to Be Acquired by Viatris 


    • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 


    • CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion